Keywords: Medicare Modernization Act; Colon cancer; SEER-Medicare; Policy; Treatment;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Depression; Head and neck cancer; Survival; SEER-Medicare; Cancer; Oncology; Epidemiology;
Keywords: Mortality; Prognosis; SEER-Medicare;
Keywords: High-risk prostate cancer; Locally advanced prostate cancer; RT-ADT; SEER-Medicare;
Keywords: Bladder cancer; Operative time; Radical cystectomy; SEER-Medicare;
Keywords: Ovarian cancer; SEER-Medicare; Cost-effectiveness; Surgery; Chemotherapy; Cost
Keywords: Outcomes research; Prostate cancer; Reconstructive urology; SEER-Medicare; Urinary adverse effects
Keywords: Infection; Myeloid Malignancy; SEER-Medicare
Keywords: Depression; Head and neck cancer; SEER-Medicare; Cancer; Oncology; Epidemiology
How does autoimmune disease impact treatment and outcomes among patients with lung cancer? A national SEER-Medicare analysis
Keywords: Lung cancer; Autoimmune disease; Immune therapy; SEER-medicare;
Metastasectomy in older adults with urothelial carcinoma: Population-based analysis of use and outcomes
Keywords: Urothelial Cancer; Bladder Cancer; Metastasectomy; Metastasis; SEER-Medicare; Surgery;
Neoadjuvant and adjuvant chemotherapy use in upper tract urothelial carcinoma
Keywords: Upper tract urothelial cancer; Chemotherapy; Neoadjuvant; Nephroureterectomy; Upper tract transitional cell carcinoma; SEER-medicare;
A population-based comparative effectiveness study of chemoradiation regimens and sequences in stage III non-small cell lung cancer
Keywords: Non-small cell lung cancer; Chemoradiation; Comparative effectiveness research; Platinum-doublet chemotherapy; SEER-Medicare;
Derivation and validation of the SEER-Medicare myelodysplastic syndromes risk score (SMMRS)
Keywords: MDS; SEER; SEER-Medicare; Prognosis; Comparative effectiveness;
Bowel obstruction in elderly ovarian cancer patients: A population-based study
Keywords: Bowel obstruction; Ovarian cancer; SEER-Medicare; Survival; Incidence;
Keywords: cost-effectiveness; hepatocellular carcinoma; SEER-Medicare; survival; transarterial chemoembolization
Assessing short- and long-term outcomes among black vs white Medicare patients undergoing resection of colorectal cancer
Keywords: Colorectal cancer; Race; Disparities; SEER-Medicare
Chemotherapy Treatment Patterns in Elderly Patients Initially Diagnosed With Advanced Ovarian Cancer
Keywords: Cytotoxic agents; First-line; Maintenance; Second-line; SEER-Medicare; Treatment duration;
Outcomes of irinotecan-based chemotherapy regimens in elderly medicare patients with metastatic colorectal cancer
Keywords: colorectal cancer; chemotherapy; irinotecan; survival; SEER-Medicare;
Radiation Therapy, Cardiac Risk Factors, and Cardiac Toxicity in Early-Stage Breast Cancer Patients
Keywords: Radiation therapy; Cardiotoxicity; Breast cancer; Elderly; SEER-Medicare;
Survival benefit associated with adjuvant androgen deprivation therapy combined with radiotherapy for high- and low-risk patients with nonmetastatic prostate cancer
Keywords: Prostate; Prostatic neoplasms; Adjuvant androgen deprivation therapy; LHRH agonists; SEER-Medicare; Instrumental variables;
Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: A population-based study
Keywords: Outcomes; SEER-Medicare; Resection; Transplant; Treatment; HCCHBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; SEER, surveillance epidemiology and end-results Program